MedPath

Community Reinforcement and Family Training (CRAFT)

Not Applicable
Completed
Conditions
Concern Significant Others
Alcohol Use Disorder
CRAFT
Interventions
Behavioral: CRAFT
Registration Number
NCT03281057
Lead Sponsor
Kjeld Andersen
Brief Summary

The present study is dedicated to empowering individuals close to an addicted person (i.e. concerned significant others, CSOs) to create changes in their family environment: changes that increase the likelihood of the addicted person seeking treatment.

The Danish National Clinical Guideline for the treatment of alcohol dependence recommends that alcohol treatment centers offer interventions aimed at CSOs, providing them with the support and empowerment that will enable them to motivate the problem drinker to enter treatment. In the US, the Community Reinforcement and Family Training (CRAFT) intervention has been shown to offer the most effective support to CSOs. CRAFT has consistently demonstrated a two to three times' higher impact on getting individual with an alcohol use disorder (AUD) to attend treatment, compared to other kinds of interventions. Studies of the intervention so far have, however, been small, and the format used in the delivery of CRAFT has not been fully investigated.

The aim of the present cluster randomized controlled trial is to implement and investigate CRAFT in a Danish context and with sufficient sample size. Consecutive CSOs will through cluster randomization be randomized to receive either CRAFT in a group format, CRAFT in an individual format, or a control condition, consisting of self-help material only. The primary outcome of the study will be the rate of individuals with AUD entering treatment following the intervention targeted at the CSOs within three months from its initiation. Data will be collected from all CSOs at baseline, three, and six months after baseline.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
255
Inclusion Criteria

Not provided

Exclusion Criteria
  • Suffering from dementia or other cognitive disorders
  • Not speaking Danish
  • Being psychotic or otherwise severely mentally ill
  • Suffering from AUD in the last three months
  • Being concerned about a person who, according to the CSO, mainly use illegal substances

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Group CRAFTCRAFTOpen group CRAFT is offered to 135 participants in 6 sessions.
Self-help materialsCRAFTSelf-help materials (control group) are going to be offered a self-help book, because it is unethically not to offer any intervention, as the CRAFT intervention in early studies have shown to be very effectful
Individual CRAFTCRAFTIndividual CRAFT is offered to 135 participants and each participants are going to get 6 sessions.
Primary Outcome Measures
NameTimeMethod
Whether the drinker has sought treatment for her/his alcohol use disorder3 months after baseline

The proportion of problem drinkers, who enter alcohol treatment centers from baseline and until three months after their CSOs enrolled in the CRAFT study.

Secondary Outcome Measures
NameTimeMethod
Changes in number of sick leave days for concern significant others from 6 months before to 6 months after enrollment in the study.6 months after baseline
Changes in quality of life among concern significant others.3 and 6 months after baseline

Measured by WHO's quality of life scale "WHOQol-Bref - Danish version"

Changes in the anxiety, - depression and concern symptoms of concern significant others following CRAFT intervention3 and 6 months after baseline
Improvement in the relationship between the concern significant other and the drinker before and after CRAFT intervention3 and 6 months after baseline

Measured by the Relationship Happiness Scale

Trial Locations

Locations (2)

Research Unit of Psychiatry, Psychiatric Unit Odense - University function

🇩🇰

Odense C, Denmark

Unit if Clinical Alcohol Research

🇩🇰

Odense, Denmark

© Copyright 2025. All Rights Reserved by MedPath